Huda Y. Zoghbi, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 800 shares at $800.00 ($640K) on 2026-08-10, disclosed to the SEC on 2026-08-12.
Scheduled sale ($640k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| REGN | SELL | 2023-10-17 | $850K | — | Filing → |
| REGN | SELL | 2022-03-18 | $1.4M | — | Filing → |
| REGN | SELL | 2021-09-15 | $650K | — | Filing → |